Author | James R. Berenson, MD | OncLive

Author | James R. Berenson, MD

Articles

Dr. Berenson Discusses Results from the CHAMPION-1 Trial

June 06, 2014

Video

James R. Berenson, MD, founder, President and Medical and Scientific Director of the Institute for Myeloma and Bone Cancer Research, President of Oncotherapeutics, discusses the dose-escalation portion of the phase I/II CHAMPION-1 study looking at weekly carfilzomib in combination with dexamethasone for patients with relapsed or refractory multiple myeloma.

Dr. Berenson on Weekly Carfilzomib For Patients With R/R Multiple Myeloma

May 09, 2014

Video

James R. Berenson, MD, discusses a phase I study presented at the 2013 ASH meeting that analyzed the use weekly carfilzomib for patients with R/R multiple myeloma.

Dr. Berenson on a Study of Pomalidomide in R/R Myeloma

December 13, 2013

Video

James R. Berenson, MD, discusses a phase I/II study looking at pomalidomide, dexamethasone and pegylated liposomal doxorubicin for patients with relapsed/refractory multiple myeloma. The study was presented at the 2013 ASH Meeting.

Dr. Berenson Discusses New Potential Targets in Myeloma

April 04, 2013

Video

James R. Berenson, MD, Medical and Scientific Director, Institute for Myeloma & Bone Cancer Research, Chief Executive Officer, Oncotherapeutics, comments on new potential targets in myeloma.

x